logo
  

Mattel Inc. Q4 Profit Misses Estimates - Quick Facts

Mattel, Inc. (MAT) reported fourth-quarter earnings per share of $0.50, compared to reported earnings per share of $0.63 in the prior year's fourth quarter; and adjusted earnings per share of $0.52, compared to adjusted earnings per share of $0.65 in the prior year's fourth quarter. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.71 for the quarter. Analysts' estimates typically exclude special items.

Fourth-quarter worldwide net sales were down 8% as reported, and down 6% in constant currency; worldwide gross sales down 5% as reported, and down 1% in constant currency. Excluding Disney Princess, worldwide gross sales flat as reported, and up mid-single digits in constant currency.

Christopher Sinclair, Chairman and CEO of Mattel, said "Our results were negatively impacted by a number of industry-wide challenges, including a significant U.S. toy category slowdown in the holiday period, and increased forex headwinds. And while our sales at retail remained strong, the slowdown triggered elevated retail promotional activity and decreased shipping, all of which had a significant impact on our gross margin."

The Board of Directors declared a 2017 first quarter cash dividend of $0.38 per share, which is flat compared to the first quarter of 2016. The dividend will be payable on March 3, 2017 to stockholders of record on February 16, 2017.

Full year 2016 reported earnings per share was $0.92, compared to reported earnings per share of $1.08 in the prior year; and adjusted earnings per share of $1.06, compared to adjusted earnings per share of $1.27 in the prior year. Worldwide net sales down 4% as reported, and down 2% in constant currency; worldwide gross sales down 3% as reported, and flat in constant currency. Excluding Disney Princess, worldwide gross sales up mid-single digits as reported, and up high-single digits in constant currency.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT